Zobrazeno 1 - 10
of 460
pro vyhledávání: '"MJ Brodie"'
Publikováno v:
British Journal of Clinical Pharmacology. 23:358-361
Antipyrine kinetics following a single oral dose were obtained in porphyric patients in attack and in remission and in controls. The clearance of antipyrine was significantly lower during an acute porphyric attack (median: 0.34 ml min-1 kg-1; range:
Publikováno v:
British Journal of Clinical Pharmacology. 12:771-777
1 The metabolism of antipyrine to its three main oxidative metabolites, 4-hydroxyantipyrine, 3-hydroxymethylantipyrine and norphenazone was investigated in vivo and in vitro in separate groups of subjects with normal hepatic function and in the same
Publikováno v:
Scopus-Elsevier
1 Methods are described for the determination of mixed function oxidase activity in microsomal fractions from percutaneous needle biopsies of human liver. 2 Activities of needle biopsy samples were comparable with those of wedge biopsy sample obtaine
Autor:
Alan R. Boobis, Colin T. Dollery, R Harrison, MJ Brodie, EL Toverud, S Webster, W Ellis, Stephen Murray
Publikováno v:
British Journal of Clinical Pharmacology. 9:523-525
Publikováno v:
British Journal of Clinical Pharmacology. 11:89-91
Autor:
Alan R. Boobis, Donald S. Davies, MJ Brodie, RY Frempong, C Whyte, Michael E. McManus, G. M. Pacifici, GC Kahn
Publikováno v:
Life sciences. 26(6)
The metabolism of xenobiotics by human lung has been investigated in tissue obtained from 10 patients undergoing pneumonectomy and compared with human liver activities in 6 different subjects. Lung microsomal fractions contain no detectable cytochrom
Publikováno v:
British journal of clinical pharmacology. 9(3)
Autor:
MJ Brodie
Publikováno v:
British journal of clinical pharmacology. 13(1)
Autor:
JC Mucklow, MJ Brodie, CJ Hillyard, BK Park, EL Toverud, Donald S. Davies, I Macintyre, HS Fraser, Colin T. Dollery, PF Wilmana
Publikováno v:
British journal of clinical pharmacology. 8(6)
1 Twenty-four Asian vegetarians had significantly lower 25-hydroxyvitamin D (25-OHD) levels and longer antipyrine half-lives than twenty white non-vegetarians (P less than 0.001). 2 Treatment with oral antipyrine over 4 or 5 weeks in seven vegetarian
Publikováno v:
British journal of clinical pharmacology. 20(1)
Phenacetin O-deethylase activity was impaired, both in vivo and in vitro, in poor metabolisers of debrisoquine, consistent with the work of others. No impairment was observed in the oxidation of acetanilide, amylobarbitone or antipyrine in the PM phe